| Overview |
| bsm-52054r-pe-cy3-100ul |
| Cytokeratin 14 Recombinant Monoclonal Antibody, PE-Cy3 Conjugated |
| WB |
| Human, Mouse, Rat |
| Specifications |
| PE-Cy3 |
| Rabbit |
| A synthesized peptide derived from human Cytokeratin 14 |
| Monoclonal |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity-chromatography |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3861 |
| P02533 |
| K14; NFJ; CK14; EBS3; EBS4; Keratin, type I cytoskeletal 14; Cytokeratin-14; CK-14; Keratin-14; KRT14 |
| The nonhelical tail domain is involved in promoting KRT5-KRT14 filaments to self-organize into large bundles and enhances the mechanical properties involved in resilience of keratin intermediate filaments in vitro. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz